Omeros Correlations
| OMER Stock | USD 11.75 0.18 1.51% |
The current 90-days correlation between Omeros and ADC Therapeutics SA is -0.01 (i.e., Good diversification). The correlation of Omeros is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Omeros Correlation With Market
Very weak diversification
The correlation between Omeros and DJI is 0.48 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Omeros and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Omeros Stock
Moving against Omeros Stock
| 0.69 | KG | Kestrel Group Symbol Change | PairCorr |
| 0.39 | ELTX | Elicio Therapeutics | PairCorr |
| 0.35 | IQ70 | 1CM INC | PairCorr |
| 0.33 | NXS | Next Science Earnings Call This Week | PairCorr |
| 0.32 | BSFA | ANI Pharmaceuticals | PairCorr |
| 0.55 | BGM | Qilian International | PairCorr |
| 0.37 | 3ZQ0 | AYURCANN HOLDINGS Earnings Call This Week | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Omeros Stock performing well and Omeros Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Omeros' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ADCT | 3.14 | 0.08 | 0.02 | 0.10 | 4.20 | 8.49 | 22.84 | |||
| NMRA | 4.28 | 0.49 | 0.12 | 0.62 | 3.70 | 10.98 | 33.25 | |||
| LXRX | 3.65 | (0.19) | 0.00 | (0.04) | 0.00 | 8.92 | 38.53 | |||
| RAPT | 3.84 | 1.40 | 0.33 | (0.53) | 2.84 | 7.87 | 64.19 | |||
| BCYC | 2.62 | (0.30) | 0.00 | (0.19) | 0.00 | 6.06 | 14.20 | |||
| FDMT | 3.80 | (0.19) | 0.00 | (0.11) | 0.00 | 7.04 | 27.09 | |||
| KALV | 3.09 | 0.26 | 0.06 | 0.30 | 3.59 | 6.19 | 20.72 | |||
| FULC | 4.25 | 0.69 | 0.14 | (0.41) | 4.01 | 11.56 | 53.80 | |||
| GOSS | 3.93 | (0.22) | 0.00 | (1.00) | 0.00 | 8.77 | 27.11 | |||
| OCGN | 3.78 | 0.24 | 0.05 | 0.32 | 4.58 | 7.25 | 32.50 |
Omeros Corporate Management
| Peter JD | General VP | Profile | |
| Nadia Dac | VP Officer | Profile | |
| Debra MT | Chief Officer | Profile | |
| David Ghesquiere | Chief Officer | Profile | |
| Andreas MD | Chief Officer | Profile | |
| Gregory MD | Chairman, CoFounder | Profile |